Poliomyelitis immunization in adults
During the last 10 years poliomyelitis has been well controlled in England, though not eradicated. In 1976/77 there were 26 cases but in the six preceding years the numbers never reached double figures, and since the 1976/77 increase only a further 2 have come to light, both of which were acquired abroad. This control has been due to the efficacy of live polio vaccine and its widespread application in children. In England paralytic poliomyelitis, when it does occur, rarely if ever affects persons who have been fully immunized. Patients who develop the disease are almost invariably unvaccinated, apart from the rare instances of vaccine-associated disease. Routine immunization begins at 3 or 6 months followed by further doses 6 weeks and 6 months later; taking the country as a whole the uptake has been reasonably satisfactory. Until recently, four-fifths of the children eligible in England and Wales were immunized and the whooping-cough vaccine scare has scarcely affected the uptake of polio vaccine.
Poliomyelitis, when it does occur in England, usually affects children and a recent report (Collingham et al. 1978) pointed out that of the 26 patients in 1976/77 only 5 were adults.
In view of the infrequency of poliomyelitis in adults it is not surprising that there should be some uncertainty as to whether polio vaccination is indicated after early life. If we could be certain that the freedom from poliomyelitis of our adults truly indicates that they are immune, there would clearly be no case for vaccination. However, antibody studies suggest that in fact a substantial proportion of adults are without immunity, certainly as judged by the absence of circulating antibody: 14% of police cadets, for example, were found to be without antibody to one or other of the three virus types (Smith et al. 1976 ). Most of the cadets had been immunized in childhood with inactivated vaccine in the days before live vaccine was introduced, and the position in this age group now is probably better. Nevertheless, the proportion of susceptibles among the population in some areas is disquieting. In the North East for example only 50% of the adults examined have antibody to all three virus types (Codd & White 1977) , and this may well be the case in other areas. Such groups probably owe their freedom from polio more to the infrequency of poliomyelitis in England than to their own immunity to the disease. In the event of a polio outbreak many adults in England might be vulnerable. Thus in the event of even a limited outbreak the adults in the area concerned should be vaccinated as soon as possible. It also follows that travellers to countries where poliomyelitis is endemic should receive vaccine, and the DHSS advise vaccination against polio for travellers to any countries other than those of Europe and North America (DHSS 1976) .
A rare but tragic complication of vaccination with attenuated polio strains is the occurrence of paralytic poliomyelitis, either in vaccinated children or their adult contacts. Vaccine-associated cases among contacts are extremely rare, perhaps about 1 for every 5 million doses of vaccine distributed (Collingham et al. 1978 ). Vaccination of adult contacts when vaccine is being given to a child in the same household might help in preventing such instances and would do something to assist the general immunity.
Two preparations, one live and the other inactivated, are currently available. The latter is usually advised if vaccine must be given during early pregnancy. Although there is no evidence that attenuated virus would endanger the fetus there is always some reluctance to vaccinate during pregnancy with live virus vaccines. Inactivated vaccine is also used for patients in whom live virus vaccine is contraindicated for other reasons, for example those on steroids. The relative merits of the two types of vaccine for boosting immunity in adultse.g. before foreign travelis still not entirely clear and further field studies are needed. However, those who have received live vaccine previously and thus possess gut immunity may not respond to a further dose of attenuated virus (Smith et al. 1976 ). For such patients a single dose of inactivated vaccine may be more suitable. On the other hand those who have been immunized previously with inactivated vaccine will, in most cases, have received it more than 20 years ago. Although there might be a satisfactory boost after so long an interval, it would seem advisable to give these patients a primary course of three doses of live vaccine as though they had never been immunized.
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